Literature DB >> 22079854

Evaluation of pulse wave velocity in systemic lupus erythematosus, rheumatoid arthritis and Behçet's disease.

Gonenc Kocabay1, Hakan Hasdemir, Mustafa Yildiz.   

Abstract

OBJECTIVES: Connective tissue diseases involve characteristic inflammatory lesions in the cardiovascular system, in addition to other systems. The involvement of the cardiovascular system in the course of connective tissue diseases may result in serious morbidity and mortality. Pulse wave velocity which is an indicator of arterial dilatation capacity may predict cardiovascular risk of patients. Pulse wave velocity is inversely proportional to arterial dilatation capacity. Decreased dilatation capacity leads to a reduction in arterial blood pressure and flow dynamics and impairment in coronary perfusion.
METHODS: In our study, we examined pulse wave velocity in frequent chronic inflammatory rheumatologic diseases: rheumatoid arthritis, systemic lupus erythematosus, and Behçet's disease. A total of 98 subjects participated in our study including 24 patients with newly diagnosed rheumatoid arthritis (4 males, 20 females; mean age 42.5 ± 11.5 years), 22 patients with newly diagnosed systemic lupus erythematosus (1 male, 21 females; mean age 35.8 ± 11.1 years), 33 patients with newly diagnosed Behçet's disease (26 males, 7 females; mean age 32.7 ± 8.0 years), and 19 healthy subjects in the control group (10 males, 9 females; mean age 36.2 ± 15.0 years). Aorta pulse wave velocity was determined by Complior Colson (Createch Industrie, Garges les Gonesses, France) device which allowed for pulse wave recording and automated measurement.
RESULTS: Pulse wave velocity was higher in rheumatoid arthritis, systemic lupus erythematosus, and Behçet's disease groups compared to the control group. When all variables were included in the regression analysis only age was found to affect pulse wave velocity independently.
CONCLUSION: Pulse wave velocity was found to be high in chronic inflammatory connective tissue diseases compared to the control group. However, no difference was found between groups. Age was determined as the most important independent variable in the regression analysis.
Copyright © 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22079854     DOI: 10.1016/j.jjcc.2011.09.004

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  13 in total

1.  Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis.

Authors:  Aysegul Kucukali Turkyilmaz; Gul Devrimsel; Aynur Kirbas; Yuksel Cicek; Murat Karkucak; Erhan Capkin; Ferhat Gokmen
Journal:  Rheumatol Int       Date:  2013-06-25       Impact factor: 2.631

Review 2.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

3.  Stiffening of aorta is more preferentially associated with rheumatoid arthritis than peripheral arteries.

Authors:  Yong Yang; Zhen Wang; Zihao Fu; Runrun Yang; Jia Wang; Lijun Yuan; Feng Gao; Yunyou Duan
Journal:  Rheumatol Int       Date:  2019-08-02       Impact factor: 2.631

Review 4.  Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis.

Authors:  Antongiulio Scarno; Fabio Massimo Perrotta; Francesca Cardini; Alessia Carboni; Gianmarco Annibali; Ennio Lubrano; Antonio Spadaro
Journal:  World J Orthop       Date:  2014-07-18

Review 5.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

6.  Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis.

Authors:  Alessandro Giollo; Giovanni Cioffi; Federica Ognibeni; Giovanni Orsolini; Andrea Dalbeni; Riccardo Bixio; Giovanni Adami; Angelo Fassio; Luca Idolazzi; Davide Gatti; Maurizio Rossini; Ombretta Viapiana
Journal:  Arthritis Res Ther       Date:  2021-06-03       Impact factor: 5.156

7.  Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis.

Authors:  Bartłomiej Kisiel; Robert Kruszewski; Aleksandra Juszkiewicz; Anna Raczkiewicz; Artur Bachta; Małgorzata Tłustochowicz; Jadwiga Staniszewska-Varga; Krzysztof Kłos; Krzysztof Duda; Romana Bogusławska-Walecka; Rafał Płoski; Witold Tłustochowicz
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

8.  The count of tender rather than swollen joints correlates with aortic stiffness in patients with rheumatoid arthritis.

Authors:  Konstantinos Triantafyllias; Michele De Blasi; Isabell Hoffmann; Thomas Thomaidis; Philipp Drees; Andreas Schwarting
Journal:  Springerplus       Date:  2016-04-11

9.  Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.

Authors:  Mónica Vázquez-Del Mercado; Felipe de J Perez-Vazquez; Eduardo Gomez-Bañuelos; Efrain Chavarria-Avila; Arcelia Llamas-García; Karla I Arrona-Rios; Gustavo Ignacio Diaz-Rubio; Sergio Durán-Barragán; Rosa E Navarro-Hernández; Bethel P Jordán-Estrada; Natalia Prado-Bachega; Miguel A A Gonzalez-Beltran; Carlos Ramos-Becerra; Fernando Grover-Paez; David Cardona-Müller; Ernesto G Cardona-Muñoz
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

10.  Determinants of brachial-ankle pulse wave velocity in Chinese patients with rheumatoid arthritis.

Authors:  Ping Li; Cheng-Xun Han; Cui-Li Ma; Jia-Long Guo; Bo Liu; Juan Du; Li-Qi Bi
Journal:  Clin Dev Immunol       Date:  2013-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.